TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 4,42
0,00%
(0,00) 1D
17 nov, 10:10:08 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TMCI genereren…
Openen
US$ 4,44
Hoog
US$ 4,56
Laag
US$ 4,37
Beursw.
289,77 mln.
Gem. vol.
305,25K
Volume
30,03K
52 wk hoog
US$ 5,43
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Openen
US$ 4,44
Hoog
US$ 4,56
Laag
US$ 4,37
Beursw.
289,77 mln.
Gem. vol.
305,25K
Volume
30,03K
52 wk hoog
US$ 5,43
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Nieuwsartikelen
Van webbronnen en nieuwspartners
TradingView
·
1 uur geleden
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
43 minuten geleden
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
11 minuten geleden
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
The Defiant
·
14 uur geleden
Ondo Launches S&P 500 Portfolio Token With Loss Buffers
Profiel
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Over Treace Medical Concepts, Inc